In SLE, IFN-I production originates from dendritic cells, neutrophils, and monocytes/macrophages ( Figure 2 IFN-I-induced endothelial cell damage and repair-imbalance accelerate atherosclerosis ( Concurrently, IFN- creates anti-angiogenic microenvironments via IL-1 pathway dysregulation (reduced IL-1/1/1R1
12-Month Treatment Comparison For one full year of treatment with the new pricing: Brand-name Wegovy (cash-pay): $4,188 ($199 2 months + $349 10 months) Compounded semaglutide: $2,388 ($199 12 months) Savings with compounded: $1,800 18-Month Treatment Comparison For typical treatment duration to reach goal weight: Brand-name Wegovy (cash-pay): $5,986 ($199 2 + $349 16) Compounded semaglutide: $3,582 ($199 18) Savings with compounded: $2,404 Long-Term Maintenance Comparison If ongoing maintenance is necessary (which research suggests for sustained results): 3 years brand-name (after intro period): $12,564 ($349 36) 3 years compounded: $7,164 ($199 36) Savings over 3 years: $5,400 For people requiring truly long-term treatment, the cumulative savings from compounded alternatives remain substantial even with reduced brand-name pricing
The FDA approved tirzepatide for weight loss in 2023
So, the smart move is to use this time to really dial in your nutrition and make healthy habits second nature
Song and Long, 2020)
